Page last updated: 2024-09-04

moxifloxacin and meropenem

moxifloxacin has been researched along with meropenem in 40 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (meropenem)	Trials (meropenem)	Recent Studies (post-2010) (meropenem)
3,157	552	1,690	3,803	284	2,253

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.50)	18.2507
2000's	16 (40.00)	29.6817
2010's	19 (47.50)	24.3611
2020's	4 (10.00)	2.80

Authors

Authors	Studies
Jolivette, LJ; Ward, KW	1
Bouza, E; Cercenado, E; Cuevas, O; Marín, M; Martínez-Alarcón, J; Sánchez-Martínez, M	1
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA	1
Finegold, SM; Golan, Y; Goldstein, EJ; Gorbach, SL; Harrell, LJ; Hecht, DW; Jacobus, NV; Jenkins, SG; McDermott, LA; Pierson, C; Rihs, J; Ruthazer, R; Snydman, DR; Venezia, R; Yu, V	1
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP	1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG	1
Lombardo, F; Obach, RS; Waters, NJ	1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC	1
Karlowsky, JA; Laing, NM; Zhanel, GG	1
Jacobus, NV; McDermott, LA; Snydman, DR	1
Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A	1
Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F	1
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ	1
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D	1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG	1
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG	1
Bergogne-Bérézin, E	1
Ghaffar, F; Hardy, RD; Jafri, HS; McCoig, CC; McCracken, GH; Michelow, IC; Olsen, K; Patel, C; Rodriguez-Cerrato, V	1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E	1
Brooke, CJ; Hampson, DJ; Riley, TV	1
Bolaños, M; Finegold, SM; Molitoris, D; Väisänen, ML	1
Cole, ST; Dhar, N; Ha, YH; Hartkoorn, RC; Sala, C; Schneider, P; Zhang, M	1
Amann, K; Bröcker, EB; Müller, PA; Trautmann, A	1
Brown, DL; Drusano, GL; Heine, HS; Kulawy, RW; Louie, A; VanScoy, BD	1
Bach, F; Bloos, F; Bogatsch, H; Brunkhorst, FM; Büchler, MW; Engel, C; Fritz, H; Gründling, M; Jaschinski, U; John, S; Kiehntopf, M; Kollef, MH; Kuhnt, E; Loeffler, M; Ludewig, K; Marx, G; Meier-Hellmann, A; Moerer, O; Nierhaus, A; Oppert, M; Putensen, C; Ragaller, M; Reill, L; Reinhart, K; Riessen, R; Seibel, A; Spies, C; Welte, T; Weyland, A	1
Cole, ST; Hartkoorn, RC; Lechartier, B	1
Himeno, A; Isozaki, T; Kawaguchi, H; Suzuki, H; Suzuki, Y	1
Böhmdorfer, M; Hetz, H; Höferl, M; Jäger, W; Klaus, D; Krenn, CG; Motal, M; Roth, GA; Schebesta, K; Schmidt, EM; Sipos, W	1
Asano, K; Betsuyaku, T; Fujiwara, H; Hasegawa, N; Miyata, J; Miyazaki, M; Naoki, K; Ohkusu, K; Sayama, K; Tasaka, S; Yoshida, S	1
Davydov, A; Karpov, I; Salavei, M; Titov, L	1
Akgul, O; Jean-Pierre, H; Justesen, US; Kulekci, G; Morris, T; Nagy, E; Soyletir, G; Ulger Toprak, N; Urban, E; Veloo, ACM; Wybo, I	1
Ikebuchi, K; Imai, K; Kawamura, T; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Ogane, K; Onodera, A; Sakai, J; Takeuchi, S; Tarumoto, N	1
Poilvache, H; Ruiz-Sorribas, A; Van Bambeke, F	1
Haerting, M; Herpertz, G; Radke, O	1
Alffenaar, JW; Aryal, S; Boorgula, GD; Dheda, K; Gumbo, T; Malinga, L; Raj, P; Shankar, P; Singh, S; Srivastava, S; Thomas, TA	1

Reviews

2 review(s) available for moxifloxacin and meropenem

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Bacillus cereus necrotizing pneumonia in a patient with nephrotic syndrome. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Aza Compounds; Bacillus cereus; Biopsy, Needle; Bronchoalveolar Lavage Fluid; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunohistochemistry; Male; Meropenem; Moxifloxacin; Necrosis; Nephrotic Syndrome; Pneumonia, Bacterial; Quinolines; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome	2013

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Bacillus cereus necrotizing pneumonia in a patient with nephrotic syndrome.

Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1

Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Aza Compounds; Bacillus cereus; Biopsy, Needle; Bronchoalveolar Lavage Fluid; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunohistochemistry; Male; Meropenem; Moxifloxacin; Necrosis; Nephrotic Syndrome; Pneumonia, Bacterial; Quinolines; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome

2013

Trials

1 trial(s) available for moxifloxacin and meropenem

Article	Year
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA, 2012, Jun-13, Volume: 307, Issue:22 Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Meropenem; Middle Aged; Moxifloxacin; Multiple Organ Failure; Quinolines; Sepsis; Shock, Septic; Survival Analysis; Thienamycins; Treatment Outcome	2012

Article

Year

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

JAMA, 2012, Jun-13, Volume: 307, Issue:22

Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Meropenem; Middle Aged; Moxifloxacin; Multiple Organ Failure; Quinolines; Sepsis; Shock, Septic; Survival Analysis; Thienamycins; Treatment Outcome

2012

Other Studies

37 other study(ies) available for moxifloxacin and meropenem

Article	Year
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7 Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution	2005
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline	2007
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles	2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Time Factors; United States	2007
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States	2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan	2008
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests	2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2008
Comparative antipneumococcal activities of sulopenem and other drugs. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline	2010
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae	2010
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare	2010
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea	2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction	2010
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux. Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2016
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline. Journal of medicinal chemistry, 2017, 05-11, Volume: 60, Issue:9 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin	2017
[New developments in pharmacology of antibiotics]. Presse medicale (Paris, France : 1983), 1998, Volume: 27 Suppl 5 Topics: Animals; Anti-Infective Agents; Aza Compounds; Disease Models, Animal; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Moxifloxacin; Quinolines; Quinolones; Thienamycins	1998
Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11 Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Ceftriaxone; Cephalosporins; Escherichia coli; Fluoroquinolones; Male; Meningitis, Escherichia coli; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Thienamycins	2001
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins	2001
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Chloramphenicol; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Metronidazole; Moxifloxacin; Quinolines; Spirochaetales; Swine; Tetracycline; Thienamycins	2003
In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5 Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Fluoroquinolones; Humans; In Vitro Techniques; Inhibitory Concentration 50; Linezolid; Meropenem; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Pyrrolidines; Quinolines; Quinolones; Thienamycins	2006
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10 Topics: Antitubercular Agents; Aza Compounds; Fluoroquinolones; Isoniazid; Meropenem; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Quinolines; Rifampin; Streptomycin; Thienamycins	2010
[Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2012, Volume: 63, Issue:3 Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aortic Valve; Aza Compounds; Biopsy; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Endocarditis, Bacterial; Eosinophilia; Fluoroquinolones; Glucocorticoids; Humans; Kidney; Legionnaires' Disease; Male; Meropenem; Moxifloxacin; Nephritis, Interstitial; Quinolines; Sepsis; Skin; Thienamycins; Vancomycin	2012
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Bacillus anthracis; Ciprofloxacin; Doxycycline; Fluoroquinolones; Linezolid; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Moxifloxacin; Oxazolidinones; Predictive Value of Tests; Quinolines; Spores, Bacterial; Thienamycins; Viral Load	2012
In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Adamantane; Antitubercular Agents; Aza Compounds; Diarylquinolines; Drug Combinations; Drug Synergism; Ethambutol; Ethylenediamines; Fluoroquinolones; Isoniazid; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Quinolines; Rifampin; Spiro Compounds; Thiazines; Thienamycins	2012
Multiple liver cyst infection caused by Salmonella ajiobo in autosomal dominant polycystic kidney disease. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:3 Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Cysts; Female; Fluoroquinolones; Humans; Liver Diseases; Meropenem; Moxifloxacin; Polycystic Kidney, Autosomal Dominant; Quinolines; Salmonella; Salmonella Infections; Thienamycins; Tomography, X-Ray Computed	2013
The effect of the molecular adsorbent recirculating system on moxifloxacin and meropenem plasma levels. Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:4 Topics: Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Meropenem; Moxifloxacin; Quinolines; Sorption Detoxification; Thienamycins	2013
First report of ceftriaxone-resistant Streptococcus pneumoniae meningitis in Belarus. Journal of global antimicrobial resistance, 2017, Volume: 11 Topics: Ceftriaxone; Dexamethasone; Drug Resistance, Bacterial; Humans; Intensive Care Units; Male; Meningitis, Pneumococcal; Meropenem; Middle Aged; Molecular Typing; Moxifloxacin; Republic of Belarus; Streptococcus pneumoniae; Treatment Outcome	2017
A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology. Anaerobe, 2018, Volume: 52 Topics: Ampicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Clindamycin; Disk Diffusion Antimicrobial Tests; Fluoroquinolones; Humans; Kuwait; Meropenem; Metronidazole; Moxifloxacin; Prevotella; Sulbactam; Thienamycins; Turkey	2018
Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe, 2020, Volume: 64 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Blood Culture; DNA Transposable Elements; Doripenem; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Japan; Meropenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin, Tazobactam Drug Combination; Prevalence; Sulbactam; Tertiary Care Centers	2020
Pharmacodynamics of Moxifloxacin, Meropenem, Caspofungin, and Their Combinations against Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2 Topics: Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Escherichia coli; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcus aureus	2022
[Case report about an initial diagnosis of HIV-infection in a young sailor through two AIDS-defining diseases with lethal progression]. Deutsche medizinische Wochenschrift (1946), 2022, Volume: 147, Issue:20 Topics: Acquired Immunodeficiency Syndrome; Adult; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Ganciclovir; HIV Infections; Humans; Meropenem; Military Personnel; Moxifloxacin; Pneumonia, Pneumocystis	2022
Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen. International journal of antimicrobial agents, 2023, Volume: 62, Issue:6 Topics: Antitubercular Agents; beta-Lactamase Inhibitors; Humans; Isoniazid; Linezolid; Meropenem; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant	2023